Satisfied medical supplier plans more acquisitions

Net profit is up at listed medical and scientific supplier Ebos, with strong performance across all markets and more acquisitions to come, the company says.

Net profit for the year ended June 30 was up 29 per cent at $11.5 million on the back of revenue of $300.5 million.

Managing director Mark Waller said performance was strong in all markets, including healthcare, consumer, aged care rehabilitation and scientific.

Acquisitions in the next year would be the main driver of growth, with a number of possibilities being evaluated.

"The next wave of this would probably be going to the market to raise funds at some point in the near future."

Challenges included a rationing of health services and increased compliance costs. There needed to be greater public private sector partnerships.

Chairman Rick Christie said it had been a demanding year, including the implementation of a new operating model for the Health Support subsidiary, completion of acquisitions in the scientific sector, redefining the strategy for Australia and managing higher interest costs.

"To still turn in a significantly improved result is a satisfying performance."

Ebos shares closed up 5c at $5.30.